Hans-Peter Ostler

Hans-Peter Ostler possesses extensive leadership experience across various sectors, currently serving as Ordförande at Vakona AB and NH3 GREENTECH, and Styrelseordförande at Hoodin. Since June 2021, Hans-Peter has held the position of Vice ordförande at Alligator Bioscience AB and continues as a Styrelseledamot at InorbitTX and Oblique Therapeutics, where responsibilities include acting as CEO and Styrelseordförande. Other positions include Styrelseledamot at Encare and Ectin Research, as well as Ordförande at A Good Choice. Hans-Peter's academic background includes studies at the University of Gothenburg and Förvaltningshögskolan vid Göteborgs Universitet. The focus areas include advancing technology, drug discovery, and environmental sustainability.